Status:
COMPLETED
Inflammatory Cytokine Quantification in Infants
Lead Sponsor:
University of Utah
Conditions:
Sepsis
Congenital Diaphragmatic Hernia
Eligibility:
All Genders
Up to 2 years
Brief Summary
This study proposes to quantify inflammatory cytokine profiles in three neonatal disease states, namely, neonatal sepsis, infants with a congenital diaphragmatic hernia defect, and infants suffering c...
Detailed Description
Very small blood samples (500 microliters) will be collected serially in these patients and analyzed with current cytokine array technology. A convenience sample of 60 patients, 20 with each of these ...
Eligibility Criteria
Inclusion
- Gestational age ≥ 34 weeks,
- Indwelling vascular catheter available for blood draws,
- Documented culture positive sepsis on vasopressors , and/or
- Congenital diaphragmatic hernia (CDH), and/or
- ECMO therapy
Exclusion
- Other major congenital anomalies
- Lack of parental consent
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01155830
Start Date
June 1 2010
End Date
June 1 2013
Last Update
May 4 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84108
2
Primary Children's Medical Center
Salt Lake City, Utah, United States, 84112